Olivier Vosters
Overview
Explore the profile of Olivier Vosters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dubois-Vedrenne I, De Henau O, Robert V, Langa F, Javary J, Al Delbany D, et al.
Front Oncol
. 2020 Jul;
10:977.
PMID: 32656083
[This corrects the article DOI: 10.3389/fonc.2019.01253.].
2.
Dubois-Vedrenne I, De Henau O, Robert V, Langa F, Javary J, Al Delbany D, et al.
Front Oncol
. 2019 Dec;
9:1253.
PMID: 31803622
Chemerin is a multifunctional protein acting mainly through the G protein-coupled receptor ChemR23/CMKLR1/Chemerin. Its expression is frequently downregulated in human tumors, including in melanoma and squamous cell carcinoma of the...
3.
Vosters O, Jaadar Y, Vidts L, Demols A, Lorent S, Lievin V, et al.
Eur J Hosp Pharm
. 2019 Jun;
25(5):281-285.
PMID: 31157040
Background: Cancer chemotherapy drugs are classified as high-risk molecules. Safety of the cancer chemotherapy process is often achieved with the implementation of a health information technology to each step or...
4.
Claes K, Vandewalle K, Laukens B, Laeremans T, Vosters O, Langer I, et al.
ACS Synth Biol
. 2016 May;
5(10):1070-1075.
PMID: 27176489
Membrane protein research is still hampered by the generally very low levels at which these proteins are naturally expressed, necessitating heterologous expression. Protein degradation, folding problems, and undesired post-translational modifications...
5.
Lombard C, Andre F, Paul J, Wanty C, Vosters O, Bernard P, et al.
PLoS One
. 2015 Jul;
10(7):e0132753.
PMID: 26214693
Background: Allergy afflicts one third of children, negatively impacting their quality of life and generating a significant socio-economic burden. To this day, this disorder remains difficult to diagnose early in...
6.
Bondue B, Sherer F, Van Simaeys G, Doumont G, Egrise D, Yakoub Y, et al.
J Nucl Med
. 2014 Dec;
56(1):127-32.
PMID: 25537989
Unlabelled: Idiopathic pulmonary fibrosis is characterized by a progressive and irreversible respiratory failure. Validated noninvasive methods able to assess disease activity are essential for prognostic purposes as well as for...
7.
Sana G, Lombard C, Vosters O, Jazouli N, Andre F, Stephenne X, et al.
Cell Transplant
. 2013 Apr;
23(9):1127-42.
PMID: 23582182
The success of liver cell therapy remains closely dependent on how well the infused cells can be accepted after transplantation and is directly related to their degree of immunogenicity. In...
8.
Bondue B, De Henau O, Luangsay S, Devosse T, de Nadai P, Springael J, et al.
PLoS One
. 2012 Jul;
7(6):e40043.
PMID: 22768214
Macrophages constitute a major component of innate immunity and play an essential role in defense mechanisms against external aggressions and in inflammatory responses. Chemerin, a chemoattractant protein, is generated in...
9.
Bondue B, Vosters O, de Nadai P, Glineur S, De Henau O, Luangsay S, et al.
PLoS Pathog
. 2011 Nov;
7(11):e1002358.
PMID: 22072972
Viral diseases of the respiratory tract, which include influenza pandemic, children acute bronchiolitis, and viral pneumonia of the elderly, represent major health problems. Plasmacytoid dendritic cells play an important role...
10.
Didierlaurent A, Morel S, Lockman L, Giannini S, Bisteau M, Carlsen H, et al.
J Immunol
. 2009 Oct;
183(10):6186-97.
PMID: 19864596
Adjuvant System 04 (AS04) combines the TLR4 agonist MPL (3-O-desacyl-4'-monophosphoryl lipid A) and aluminum salt. It is a new generation TLR-based adjuvant licensed for use in human vaccines. One of...